← FDA Drug Approvals (Drugs@FDA)
AMPHOTERICIN B
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SPIL · Approved 2021-12-14
Drug application
- FDA Application #
ANDA212514- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMPHOTERICIN B
- Generic name
- AMPHOTERICIN B
- Active ingredients
- AMPHOTERICIN B
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SPIL
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- First approval
- 2021-12-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown